Skip to main content
. 2023 Jun 30;19(2):43–50. doi: 10.1900/RDS.2023.19.43

Table 1.

Demographics, clinical characteristics and patient outcomes

Factors Values Admissions had at least one episode of hypoglycaemia (≤ 3.9
mmol/L)
Admissions had at least one episode of hyperglycaemia (≥ 10
mmol/L)
Admissions had at least one episode of significant hyperglycaemia (≥ 14 mmol/L) Total
No Yes P-value No Yes P-value No Yes P-
value
N=4,901
N=3,598 N=360 N=1,505 N=2,453 N=2,620 N=1,338
Age at admission (years) [mean ± SD] 66.7 (15.5) 64.6 (16.0) 0.01 69.1 (14.0) 64.9 (16.3) <0.01 68.2 (14.4) 63.4 (17.2) <0.01 67.0 (15.4)
15-39 227 (6.3%) 33 (9.2%) 0.07 46 (3.1%) 214 (8.7%) <0.01 106 (4.0%) 154 (11.5%) <0.01 292 (6.0%)
Age group 40-65 1,269 (35.3%) 132 (36.7%) 504 (33.5%) 897 (36.6%) 900 (34.4%) 501 (37.4%) 1,695 (34.6%)
65+ 2,102 (58.4%) 195 (54.2%) 955 (63.5%) 1,342 (54.7%) 1,614 (61.6%) 683 (51.0%) 2,914 (59.5%)
Gender Female 1,551 (43.1%) 180 (50.0%) 0.01 673 (44.7%) 1,058 (43.1%) 0.33 1,136 (43.4%) 595 (44.5%) 0.51 2,168 (44.2%)
Male 2,047 (56.9%) 180 (50.0%) 832 (55.3%) 1,395 (56.9%) 1,484 (56.6%) 743 (55.5%) 2,733 (55.8%)
Māori Non-Māori 2,357 (65.9%) 211 (59.1%) <0.01 948 (63.4%) 1,620 (66.5%) 0.05 1,672 (64.3%) 896 (67.3%) 0.06 3,228 (66.4%)
Māori 1,218 (34.1%) 146 (40.9%) 547 (36.6%) 817 (33.5%) 929 (35.7%) 435 (32.7%) 1,632 (33.6%)
Type of diabetes Type 1 Type 2 273 (7.6%) 3,325 (92.4%) 67 (18.6%) 293 (81.4%) <0.01 51 (3.4%) 1,454 (96.6%) 289 (11.8%) 2,164 (88.2%) <0.01 118 (4.5%) 2,502 (95.5%) 222 (16.6%) 1,116 (83.4%) <0.01 373 (7.6%) 4,528 (92.4%)
30 days readmission 560 (15.6%) 53 (14.7%) 0.67 225 (15.0%) 388 (15.8%) 0.46 398 (15.2%) 215 (16.1%) 0.47 731 (14.9%)
60 days readmission 740 (20.6%) 91 (25.3%) 0.04 303 (20.1%) 528 (21.5%) 0.30 533 (20.3%) 298 (22.3%) 0.16 996 (20.3%)
90 days readmission 861 (23.9%) 105 (29.2%) 0.03 342 (22.7%) 624 (25.4%) 0.05 606 (23.1%) 360 (26.9%) <0.01 1,156 (23.6%)
365 days readmission 1,152 (32.0%) 141 (39.2%) <0.01 455 (30.2%) 838 (34.2%) 0.01 808 (30.8%) 485 (36.2%) <0.01 1,521 (31.0%)
Length of stay (weeks)
[mean ± SD] 1.3 (1.8) 2.2 (2.8) <0.01 1.1 (1.5) 1.6 (2.2) <0.01 1.2 (1.7) 1.7 (2.3) <0.01 1.3 (1.8)
Admission to HDU/ICU 13 (0.4%) 1 (0.3%) 0.80 5 (0.3%) 9 (0.4%) 0.86 11 (0.4%) 3 (0.2%) 0.33 19 (0.4%)
Target Range 2,300 (63.9%) 291 (80.8%) <0.01 1,490 (99.0%) 1,101 (44.9%) <0.01 2,274 (86.8%) 317 (23.7%) <0.01 2,591 (52.9%)
Mildly
Hyperglycaemia 968 (26.9%) 45 (12.5%) 0 (0.0%) 1,013 (41.3%) 331 (12.6%) 682 (51.0%) 1,013 (20.7%)
Glucose Category Significant Hyperglycaemia 330 (9.2%) 9 (2.5%) 0 (0.0%) 339 (13.8%) 0 (0.0%) 339 (25.3%) 339 (6.9%)
Hypoglycaemia 0 (0.0%) 15 (4.2%) 15 (1.0%) 0 (0.0%) 15 (0.6%) 0 (0.0%) 15 (0.3%)
Missing 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 943 (19.2%)
Mean blood glucose [mean ± SD] 9.5 (3.2) 7.8 (2.5) <0.01 6.8 (1.3) 11.0 (3.0) <0.01 7.8 (1.9) 12.4 (3.1) <0.01 9.4 (3.2)
Glucose checked at least once every 24 hours 1,073 (29.8%) 203 (56.4%) <0.01 280 (18.6%) 996 (40.6%) <0.01 650 (24.8%) 626 (46.8%) <0.01 1,276 (26.0%)
Ketones checked at least once
during admission in Type 1
diabetes patients
90 (33.0%) 21 (31.3%) 0.80 6 (11.8%) 105 (36.3%) <0.01 23 (19.5%) 88 (39.6%) <0.01 113 (30.3%)
BGL checks per 24 hours of stay <1 BGL check
1-3 BGL checks
≥4 BGL checks
Missing
2,525 (70.2%)
1,044 (29.0%)
29 (0.8%)
0 (0.0%)
157 (43.6%)
194 (53.9%)
9 (2.5%)
0 (0.0%)
<0.01 1,225 (81.4%)
279 (18.5%)
1 (0.1%)
0 (0.0%)
1,457 (59.4%)
959 (39.1%)
37 (1.5%)
0 (0.0%)
<0.01 1,970 (75.2%)
594 (44.4%)
32 (2.4%)
0 (0.0%)
712 (53.2%)
594 (44.4%)
32 (2.4%)
0 (0.0%)
<0.01 2,682 (54.7%
1,238 (25.3%)
38 (0.8%)
943 (19.2%)
HbA1c checked
within 3 months of admission
2,187 (60.8%) 234 (65.0%) 0.12 852 (56.6%) 1,569 (64.0%) <0.01 1,556 (59.4%) 865 (64.6%) <0.01 2,932 (59.8%)
HbA1c values [mean ± SD] 63.2 (22.2) 67.4 (23.1) <0.01 52.7 (15.4) 69.6 (23.2) <0.01 57.2 (18.3) 75.1 (24.2) <0.01 61.9 (21.7)